Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01736033Phase 4Unknown
Phase 4, randomised, double-blind trial of finasteride in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Clinical Progression. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01736033.